Not logged in Share Save
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer Alison M Schram, MD; Soo-Ryum Yang, MD; Genessa Kahn; Rogelio Velasco, MD; Matteo Repetto, MD; Richard Kinh Gian Do, MD, PhD; Sara DiNapoli, PhD; Purvil Sukhadia, MS; Megan Troxel, MS; Kerem Ozcan, MD; Zeynep Tarcan, MD; Marc Ladanyi, MD; James J Harding, MD; Alexander Drilon, MD; Olca Basturk, MD; Eileen M O’Reilly, MD; null Share Save
Share Save
Share Save
Share Save
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma Sharib, Jeremy; Rhodin, Kristen E.; Liu, Annie; Mcintyre, Sarah; Bartholomew, Alex; Masoud, Sabran; Delaura, Isabel; Kemeny, Nancy E.; Cercek, Andrea; Harding, James J.; O'Reilly, Eileen M.; Abou-Alfa, Ghassan K.; Reidy-Lagunes, Diane; Connell, Louise Catherine; El Dika, Imane; Balachandran, Vinod P.; Drebin, Jeffrey; Soares, Kevin C.; Wei, Alice C.; Kingham, T. Peter; D'Angelica, Michael I.; Uronis, Hope; Strickler, John; Hsu, S. David; Morse, Michael; Zani, Sabino; Allen, Peter J.; Jarnagin, William R.; Lidsky, Michael E. Share Save
Clinical and Genomic Characterization of ERBB2-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort Mondaca, Sebastian; Walch, Henry; Sepulveda, Santiago; Schultz, Nikolaus; Munoz, Gonzalo; Yaqubie, Amin; Macanas, Patricia; Pareja, Claudia; Garcia, Patricia; Chatila, Walid; Nervi, Bruno; Li, Bob; Harding, James J.; Viviani, Paola; Roa, Juan Carlos; Abou-Alfa, Ghassan K. Share Save
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy Cowzer, Darren; Soares, Kevin; Walch, Henry; Gonen, Mithat; Boucher, Taryn M.; Do, Richard K. G.; Harding, James J.; Varghese, Anna M.; Reidy-Lagunes, Diane; Saltz, Leonard; Connell, Louise C.; Abou-Alfa, Ghassan K.; Wei, Alice C.; Schultz, Nikolaus; Kingham, T. Peter; D'Angelica, Michael, I; Drebin, Jeffrey A.; Balachandran, Vinod; Sanchez-Vega, Francisco; Kemeny, Nancy E.; Jarnagin, William R.; Cercek, Andrea Share Save
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database Schleimer, Lauren E.; Kalvin, Hannah L.; Ellis, Ryan J.; Kingham, T. Peter; Soares, Kevin C.; D'Angelica, Michael I.; Balachandran, Vinod P.; Drebin, Jeffrey; Cercek, Andrea; Abou-Alfa, Ghassan K.; O'Reilly, Eileen M.; Harding, James J.; Goenen, Mithat; Wei, Alice C.; Jarnagin, William R. Share Save
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer Harding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Lindsey, Stacie; Bachini, Melinda; Morement, Helen; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham Share Save
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma Abou-Alfa, Ghassan K.; Meyer, Tim; Do, Richard Kinh Gian; Piha-Paul, Sarina A.; Light, Joseph S.; Sherrin, Scott; Yaqubie, Amin; O'Neill, Alison Clemens; Harding, James J.; Al-Rajabi, Raed; Denlinger, Crystal S.; Cano, Pablo; Cornelius, Albert S.; O'Reilly, Eileen M.; Diprimeo, Daniel; Eli, Lisa D.; Gordan, John D.; Solit, David B. Share Save
Targeted next generation sequencing (NGS) of cell free (cf) DNA in biliary tract cancer (BTC) Cowzer, D.; Seier, K.; Darmofal, M.; Shin, P.; Khalil, D.; Walch, H.; Shia, J.; Park, W.; Eldika, I.; Chatila, W.; Schultz, N.; Wei, A.; Cercek, A.; O'Reilly, E. M.; Solit, D.; Gonen, M.; Berger, M.; Abou-Alfa, G. K.; Jarnagin, W.; Harding, J. J. Share Save
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial Grivas, Petros; Garralda, Elena; Meric-Bernstam, Funda; Mellinghoff, Ingo K.; Goyal, Lipika; Harding, James J.; Dees, E. Claire; Bahleda, Rastislav; Azad, Nilofer S.; Karippot, Asha; Kurzrock, Razelle; Tabernero, Josep; Kononen, Juha; Ng, Matthew C. H.; Mehta, Rutika; Uboha, Nataliya V.; Bigot, Frederic; Boni, Valentina; Bowyer, Samantha E.; Breder, Valeriy; Cervantes, Andres; Chan, Nancy; Cleary, James M.; Dhawan, Mallika; Eefsen, Rikke L.; Ewing, James; Graham, Donna M.; Guren, Tormod K.; Won Kim, Jin; Koynov, Krassimir; Oh, Do-Youn; Redman, Rebecca; Yen, Chia-Jui; Spetzler, David; Roubaudi-Fraschini, Marie-Claude; Nicolas-Metral, Valerie; Ait-Sarkouh, Rafik; Zanna, Claudio; Ennaji, Abdallah; Pokorska-Bocci, Anna; Flaherty, Keith T. Share Save
ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma Franssen, Stijn; Holster, Jessica J.; Jolissaint, Joshua S.; Nooijen, Lynn E.; Cercek, Andrea; D'Angelica, Michael I.; Homs, Marjolein Y. V.; Wei, Alice C.; Balachandran, Vinod P.; Drebin, Jeffrey A.; Harding, James J.; Kemeny, Nancy E.; Kingham, T. Peter; Kluempen, Heinz-Josef; Mostert, Bianca; Swijnenburg, Rutger-Jan; Soares, Kevin C.; Jarnagin, William R.; Koerkamp, Bas Groot Share Save
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma Franssen, Stijn; Holster, Jessica J.; Jolissaint, Joshua S.; Nooijen, Lynn E.; Cercek, Andrea; D'Angelica, Michael I.; Homs, Marjolein Y. V.; Wei, Alice C.; Balachandran, Vinod P.; Drebin, Jeffrey A.; Harding, James J.; Kemeny, Nancy E.; Kingham, T. Peter; Klumpen, Heinz-Josef; Mostert, Bianca; Swijnenburg, Rutger-Jan; Soares, Kevin C.; Jarnagin, William R.; Koerkamp, Bas Groot Share Save
Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study Wasan, H. S.; Harding, J. J.; Fan, J.; Oh, D-Y.; Choi, H. J.; Kim, J. W.; Chang, H-M.; Bao, L.; Sun, H.; Macarulla, T.; Xie, F.; Metges, J-P.; Ying, J.; Bridgewater, J. A.; Tejani, M.; Chen, E. Y.; Ducreux, M. P.; Ma, J.; Garfin, P.; Pant, S. Share Save
Phase I study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor, in patients with advanced cholangiocarcinoma, urothelial carcinoma and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations Garmezy, B.; Borad, M.; Lin, C. C.; Chen, L. T.; Perez, C. A.; Kato, S.; Tam, B.; Severson, P.; Quah, C. S.; Harding, J. J. Share Save
A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH1 and IDH2, as monotherapy and in combination with cisplatin and gemcitabine in advanced IDH-mutant cholangiocarcinoma Harding, J.; Ikeda, M.; Goyal, L.; Rodon, J.; Bai, L.; Oh, D.; Park, J.; Chen, L.; Ueno, M.; Liao, C.; Kondo, S.; Cosman, R.; Yokota, T.; Shroff, R.; Satoh, T.; Palmieri, L.; Hollebecque, A.; Adeva, J.; Bender, M.; Liu, H.; Macarulla, T. Share Save
Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy Keane, F.; Cowzer, D.; Khalil, D.; Shia, J.; Do, R.; Folorunso, S.; El Dika, I.; Yaqubie, A.; Kim, T.; O'Reilly, E.; Abou-Alfa, G.; Harding, J. Share Save
Phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced cholangiocarcinoma (CCA) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations Harding, J.; Perez, C.; Kato, S.; Sharma, M.; Garmezy, B.; Quah, C.; Tam, B.; Severson, P. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
